公司介绍

苏州华测生物技术有限公司

苏州华测生物技术有限公司(以下简称:华测生物)是一家专业从事新药临床前研究技术外包服务的企业,由华测检测认 证集团股份有限公司(股票代码:300012)于2011年在苏州昆山投资成立。目前华测生物已发展成为设施先进、技术一流、 实力雄厚的专业化药物安全性评价中心。公司已通过的权威认证有:国家食品药品监督管理总局(CFDA)的药物GLP认证 (2016年2月)。中国合格评定国家认可委员会(CNAS)的实验室认可证书(2017年9月)。国际AAALAC完全认证(2017年11 月)。公司严格遵循CFDA和FDA等的GLP规范,致力于为国内外生物医药企业、科研机构等客户提供安全性评价、药代/毒 代动力学生物分析测试及药效学等“一站式”技术服务。

华测生物天然具有区位优势:位于昆山高新区,毗邻苏州工业园区,东倚创新药物基地上海,处于长三角生物医药产业集 群的核心位置。华测生物占地72亩,一期工程建有符合国际GLP标准的实验室13,300多平方米。公司拥有卓越的人才队伍: CFDA新药评审专家3人,GLP检查专家2人。核心技术团队120余人,其中高级职称6人,本科及以上学历超过50%,教育 背景涵盖医学、药理学、毒理学、动物医学、生物学等。


CTI Biotechnology (Suzhou) Co., Ltd.(hereinafter referred as CTI BIO) is a CRO company specializing in the preclinical research for new drugs,invested by Centre Testing International Corporation (Stock Code: 300012) in 2011 in Kunshan Suzhou. Now CTI BIO is a professional drug safety evaluation center with advanced facilities, first -class technology and strong technical strength.Authorized certificates:China Food & Drug Adminstration official GLP certificate (February 2016).The laboratory accreditation certificate ofChina National Accreditation Commit -tee for conformity assessment (CNAS) (September 2017).AAALAC International full accreditation (November 2017). We are committed to providing one-stop technical service, such as safety evaluation, pharmacokinetic/toxicokinetic bioanalysis and pharmacodynamics, for customers of domestic and oversea biomedical enterprises and scientific research institutions.

CTI BIO has geographical advantages by nature: located in Kunshan New & High-Tech Development Zone, adjacent to Suzhou Industrial Park Zone, with new drug innovation base Shanghai in east, enjoying the geographical advantage in the core position of Yangtze River Delta medicine industrial cluster.CTI BIO occupies 72 mu, and the facility of Phase I project covers 13,300 square meters with laboratories in comply with international GLP standards. CTI BIO has an excellent talent team: 3 CFDA new drug reviewers and 2 GLP investigators. The core technology team is consist of more than 120 people, including 6 members with senior professional titles, and over 50% with bachelor’s degree or above, with education background in medicine, pharmacology, toxicology, animal medicine, biology, etc..

  • 药代动力学研究

  • 安全性研究评价

  • 药效学研究

苏州华测
苏州华测